ASARINA PHARMA AB

Other languages Asarina Pharma AB

Equities

ASAP

SE0011641794

Delayed Nasdaq Stockholm Other stock markets 04:17:54 30/04/2024 pm IST			5-day change	1st Jan Change
0.968 ^SEK	-1.22%		+7.56%	+10.00%

27/02	Asarina Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Asarina Pharma AB Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Asarina Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
Asarina Pharma AB Reports Earnings Results for the Half Year Ended June 30, 2023	23/23/23
Asarina Pharma's Positive Phase IIa Tourette Syndrome Results to Be Presented At Ticcon, the Virtual National Conference of the Tourette Association of America	05/23/05
Asarina Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27
Asarina Pharma Completes Recruitment of Patients to its Phase IIa Clinical Study in Tourette Syndrome	14/22/14
Asarina Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	25/22/25
Asarina Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2022	25/22/25
Asarina Pharma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	24/22/24
Asarina Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2021	24/22/24
Asarina Pharma AB Announces That `First Patient First Visit' Has Taken Place in Its Phase Ii A Clinical Study in Tourette Syndrome At Bispebjerg University Hospital, Copenhagen	16/22/16
Asarina Pharma Receives Final Approval for Phase IIa Tourette Study	22/21/22
Asarina Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	25/21/25
Asarina Pharma AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021	19/21/19
Asarina Pharma AB Publ Reports Earnings Results for the First Quarter Ended March 31, 2021	18/21/18
Asarina Pharma AB Publ Reports Earnings Results for the Third Quarter Ended September 30, 2020	25/20/25
Asarina Pharma AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2020	19/20/19

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer